Crizotinib, a Novel Inhibitor of ALK, Induces Apoptosis and Down Regulation of pSTAT3 in ALK+ Anaplastic Large Cell Lymphoma

被引：0
|
作者：
Hamedani, F. Saei
Mo, Z.
Amin, H. M.
Cervania, M. A.
Alkan, S.
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1502
引用
收藏
页码：359A / 359A
页数：1
相关论文
共 50 条
  • [31] Combination of crizotinib and chemotherapy in patients with relapsed or refractory anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL)
    Chen, Mei-ting
    Fu, Xiao-hong
    Huang, He
    Wang, Zhao
    Fang, Xiao-jie
    Yao, Yu-Yi
    Ren, Quan-Guang
    Chen, Ze-geng
    Lin, Tong-yu
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 571 - 580
  • [32] EBV+ ALK+ large B-cell lymphoma
    Liu, Hui
    Hu, Shimin
    BLOOD, 2021, 138 (25) : 2741 - 2741
  • [33] Anaplastic large cell lymphoma, ALK-negative
    Ferreri, Andres J. M.
    Govi, Silvia
    Pileri, Stefano A.
    Savage, Kerry J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (02) : 206 - 215
  • [34] Difficulties in diagnosis of anaplastic large cell lymphoma, alk
    Kolenova, Alexandra
    Eizmár, Andrej
    Jindrova, Jana
    Kaiserova, Emilia
    Sejnova, Daniela
    Fiedlerova, Katarina
    Zakovieova, Alena
    Plank, Lukas
    Mejstrikova, Ester
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 579 - 580
  • [35] Anaplastic large cell lymphoma, ALK-positive
    Ferreri, Andres J. M.
    Govi, Silvia
    Pileri, Stefano A.
    Savage, Kerry J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 83 (02) : 293 - 302
  • [36] Posttransplant lymphoproliferative disorder presenting as CD30+, ALK+, anaplastic large cell lymphoma in a child
    Sebire, NJ
    Malone, M
    Ramsay, AD
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2004, 7 (03) : 290 - 293
  • [37] ALK+ anaplastic large cell lymphoma expressing CD33 and myeloid nuclear differentiation antigen
    Mancera, Miguel Gonzalez
    Silva, Oscar
    BLOOD, 2025, 145 (10) : 1098 - 1098
  • [38] Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
    Subbiahy, V.
    Kuraviy, S.
    Ganguly, S.
    Welch, D. R.
    Vivian, C. J.
    Mushtaq, M. U.
    Hegde, A.
    Iyer, S.
    Behrang, A.
    Ali, S. M.
    Madison, R. W.
    Venstrom, J. M.
    Jensen, R. A.
    McGuirk, J. P.
    Amin, H. M.
    Balusu, R.
    ESMO OPEN, 2021, 6 (04)
  • [39] The γ-secretase inhibitor GSI-I interacts synergistically with the proteasome inhibitor bortezomib to induce ALK+ anaplastic large cell lymphoma cell apoptosis (vol 59, pg 76, 2019)
    Dang, Qingxiu
    Chen, Lili
    Xu, Mengqi
    You, Xuefen
    Zhou, Hong
    Zhang, Yaping
    Shi, Wenyu
    CELLULAR SIGNALLING, 2024, 113
  • [40] Partial deletion of the ALK gene in ALK-positive anaplastic large cell lymphoma
    Fukuhara, Suguru
    Nomoto, Junko
    Kim, Sung-Won
    Taniguchi, Hirokazu
    Maeshima, Akiko Miyagi
    Tobinai, Kensei
    Kobayashi, Yukio
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 150 - 158
12345